The notion that MEK/ERK signalling inhibits TSC in ALK+ ALCL is supported by the finding that treatment of SU-DHL-1 cells with MEK inhibitors resulted in decreased phosphorylation of TSC2 on inhibitory serine 1798 [127]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.